Beret Leone is a native Minnesotan who joined the WCCO team as a reporter in September 2022 - and she's thrilled be back home in the Twin Cities! Beret grew up in Chaska and graduated from Bethel ...
GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3, after its cobolimab candidate flunked a phase 3 trial in lung cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback